Skip to main content
. 2011 Aug 13;26(12):1441–1449. doi: 10.1007/s11606-011-1816-4

Table 4.

Benefits and Harms of Screening Colonoscopy for Men

Age Comorb-idities A Life expectancy (years) B Reduction in colorectal cancer mortality from screening (per 100,000/year) C Colonoscopy mortality rates (per 100,000) D Pay-off time (years) E Will average person live past pay-off time? F Number of years alive past pay-off time G Number of life-years saved (per 100,000 patients screened)
67-69
0 15.1 62.4 15.4 5.2 Yes 10.0 1128
1-2 11.1 57.9 23.1 5.3 Yes 5.8 519
≥3 7.4 33.8 46.1 5.9 Yes 1.5 81
70-74
0 13.1 89.1 15.4 5.1 Yes 8.0 852
1-2 9.7 76.9 23.1 5.3 Yes 4.5 382
≥3 6.5 52.8 46.1 5.9 Yes 0.6 28
75-79
0 10.3 109.2 23.1 5.2 Yes 5.1 459
1-2 7.7 89.9 34.6 5.4 Yes 2.3 139
≥3 5.3 53.4 69.2 6.5 No -- 0
80-84
0 7.9 116.9 30.7 5.3 Yes 2.6 232
1-2 5.9 83.0 46.1 5.7 Yes 0.2 12
≥3 4.3 46.9 92.2 7.6 No -- 0
85-94
0 6.1 90.5 30.7 5.3 Yes 0.7 65
1-2 4.6 61.6 46.1 5.7 No -- 0
≥3 3.5 36.0 92.2 7.6 No -- 0

A. Average life expectancy determined using life table approach

B. Colorectal cancer mortality rate among non-screened minus colorectal cancer mortality rate among screened patients; assumed to start 5 years after screening occurs

C. Estimated from Gatto et al.43

D. Number of years until the benefits of SC outweigh the risks

E. Does life expectancy exceed pay-off time?

F. Life expectancy minus pay-off time—indicates the number was not estimated because life expectancy does not exceed pay-off time